A Comparison of the TIMI, GRACE and HEART Scores
- Conditions
- Acute Coronary Syndrome
- Registration Number
- NCT01398631
- Lead Sponsor
- R&D Cardiologie
- Brief Summary
Various elements of patient history are checked and entered in the admission Case Recor Form (CRF). Three risk scores are calculated out of these elements, combined with physical examination, laboratory values and ECG-findings.
The primary aim is to assess the positive and negative predictive values for a cardiovascular event of the three risk scores for chest pain patients.
Secondary aim is to assess the sensitivity and specificity of various elements in the patient history for an acute coronary syndrome.
- Detailed Description
This is a prospective, observational study in patients admitted to the emergency room for chest pain. All patients are checked by the resident in charge immediately on admission, before any lab values are known, by means of an admission Case Report Form (CRF), consisting of classical elements of patient history, risk factors, medication and physical examination. This CRF is filled out immediately by the resident. No additional effort will be asked of the patients.
Patient data during a follow up of at least 6 weeks are gathered from hospital charts.
The predictive value of the three scoring systems: HEART (History, ECG, Age, Risk factors, Troponin), TIMI (Thrombolysis in Myocardial Infarction) and GRACE (Global Registry of Acute Coronary Events) for both the discharge diagnosis and the occurrence of Major Adverse Cardiovascular Events (MACE) is calculated.
The primary hypothesis of the study is that the HEART score is a significantly better predictor than the TIMI and/or GRACE score for cardiovascular events during a six week period following admission to the emergency room.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2440
- any patient visiting the cardiology emergency room due to chest pain
- chest pain clearly due to rhythm disturbances or acute heart failure
- concomitant non cardiac disease with expected fatal outcome within 1 year
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Occurence of MACE (Major Adverse Cardiac Events) 6 weeks after presentation The number of patients diagnosed with MACE (Acute Myocardial Infarction, Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting, Significant stenosis with conservative therapy, Death)
- Secondary Outcome Measures
Name Time Method The number of patients undergoing Coronary ArterioGraphy (CAG) Three months after presentation The number of patients suffering Acute Coronary Syndrome (ACS) 3 months after presentation According to adjudication committee
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (9)
Meander Medical Centre
🇳🇱Amersfoort, Netherlands
Gelre Hospital
🇳🇱Apeldoorn, Netherlands
Reinier de Graaf Gasthuis
🇳🇱Delft, Netherlands
Medical Centre Haaglanden
🇳🇱Den Haag, Netherlands
University Medical Centre Groningen
🇳🇱Groningen, Netherlands
Medical Centrum Haaglanden
🇳🇱Leidschendam, Netherlands
St Antonius Hospital
🇳🇱Utrecht, Netherlands
University Medical Centre Utrecht
🇳🇱Utrecht, Netherlands
Hofpoort Hospital
🇳🇱Woerden, Netherlands
Meander Medical Centre🇳🇱Amersfoort, Netherlands